KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 188 filers reported holding KRYSTAL BIOTECH INC in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $186,296 | +128.3% | 1,606 | +131.1% | 0.01% | +100.0% |
Q2 2023 | $81,593 | +105864.9% | 695 | -27.3% | 0.00% | +50.0% |
Q1 2023 | $77 | +148.4% | 956 | +148.3% | 0.00% | +100.0% |
Q4 2022 | $31 | -100.0% | 385 | -88.9% | 0.00% | -75.0% |
Q3 2022 | $242,000 | +33.7% | 3,477 | +25.7% | 0.00% | 0.0% |
Q2 2022 | $181,000 | -13.0% | 2,767 | -11.5% | 0.00% | +100.0% |
Q1 2022 | $208,000 | -46.8% | 3,126 | -44.2% | 0.00% | -71.4% |
Q4 2021 | $391,000 | +210.3% | 5,599 | +132.3% | 0.01% | +133.3% |
Q3 2021 | $126,000 | 0.0% | 2,410 | +30.1% | 0.00% | 0.0% |
Q2 2021 | $126,000 | +44.8% | 1,852 | +65.7% | 0.00% | +200.0% |
Q1 2021 | $87,000 | +123.1% | 1,118 | +73.6% | 0.00% | 0.0% |
Q4 2020 | $39,000 | +178.6% | 644 | +99.4% | 0.00% | – |
Q3 2020 | $14,000 | -90.8% | 323 | -91.2% | 0.00% | -100.0% |
Q2 2020 | $152,000 | +133.8% | 3,672 | +211.2% | 0.01% | +20.0% |
Q4 2019 | $65,000 | +182.6% | 1,180 | +72.8% | 0.01% | +150.0% |
Q3 2019 | $23,000 | -68.1% | 683 | -61.9% | 0.00% | -60.0% |
Q2 2019 | $72,000 | +200.0% | 1,795 | +57.5% | 0.01% | +150.0% |
Q4 2018 | $24,000 | -47.8% | 1,140 | -56.6% | 0.00% | -33.3% |
Q3 2018 | $46,000 | – | 2,627 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |